BRIC Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: July 09, 2025 Report Code: GDME20408CRDB-ST

Select Item

GlobalData’s “BRIC Cardiac Disease Market Outlook to 2033” is a comprehensive databook report, covering key market data on the BRIC Cardiac Disease market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Marker Tests

The BRIC Cardiac Disease Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Cardiac Disease Market.
• Global corporate-level profiles of key companies operating within the BRIC Cardiac Disease Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

BRIC Cardiac Disease is segmented as follows –

• Cardiac Marker Tests

Reasons to Buy

The BRIC Cardiac Disease Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Cardiac Disease Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Cardiac Disease Market, BRIC 10

3.1 Cardiac Disease Market, BRIC, Revenue ($m), 2018-2033 10

3.2 Cardiac Disease Market, BRIC, Revenue ($m), 2018-2033 11

3.3 Cardiac Disease Market, BRIC, Volume (Units), 2018-2033 12

3.4 Cardiac Disease Market, BRIC, Volume (Units), 2018-2033 13

3.5 Cardiac Disease Market, BRIC, Company Share by Revenue ($m), 2024 15

4 Cardiac Disease Market, India 16

4.1 Cardiac Disease Market, India, Revenue ($m), 2018-2033 16

4.1.1 Cardiac Marker Tests Market, India, Revenue ($m), by Segment, 2018-2033 17

4.2 Cardiac Disease Market, India, Volume (Units), 2018-2033 19

4.2.1 Cardiac Marker Tests Market, India, Volume (Units), by Segment, 2018-2033 21

4.3 Cardiac Disease Market, India, Average Price ($), 2018-2033 24

4.4 Cardiac Disease Market, India, Company Share by Revenue ($m), 2024 25

5 Cardiac Disease Market, Brazil 26

5.1 Cardiac Disease Market, Brazil, Revenue ($m), 2018-2033 26

5.1.1 Cardiac Marker Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 27

5.2 Cardiac Disease Market, Brazil, Volume (Units), 2018-2033 29

5.2.1 Cardiac Marker Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 31

5.3 Cardiac Disease Market, Brazil, Average Price ($), 2018-2033 34

5.4 Cardiac Disease Market, Brazil, Company Share by Revenue ($m), 2024 35

6 Cardiac Disease Market, China 36

6.1 Cardiac Disease Market, China, Revenue ($m), 2018-2033 36

6.1.1 Cardiac Marker Tests Market, China, Revenue ($m), by Segment, 2018-2033 37

6.2 Cardiac Disease Market, China, Volume (Units), 2018-2033 39

6.2.1 Cardiac Marker Tests Market, China, Volume (Units), by Segment, 2018-2033 41

6.3 Cardiac Disease Market, China, Average Price ($), 2018-2033 44

6.4 Cardiac Disease Market, China, Company Share by Revenue ($m), 2024 45

7 Cardiac Disease Market, Russia 46

7.1 Cardiac Disease Market, Russia, Revenue ($m), 2018-2033 46

7.1.1 Cardiac Marker Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 47

7.2 Cardiac Disease Market, Russia, Volume (Units), 2018-2033 49

7.2.1 Cardiac Marker Tests Market, Russia, Volume (Units), by Segment, 2018-2033 51

7.3 Cardiac Disease Market, Russia, Average Price ($), 2018-2033 54

7.4 Cardiac Disease Market, Russia, Company Share by Revenue ($m), 2024 55

8 Overview of Key Companies in BRIC Cardiac Disease Market 56

8.1 Abbott Laboratories 56

8.1.1 Company Overview 56

8.2 F. Hoffmann-La Roche Ltd 56

8.2.1 Company Overview 56

8.3 Siemens Healthineers AG 56

8.3.1 Company Overview 56

8.4 Beckman Coulter Inc 56

8.4.1 Company Overview 56

8.5 Quidel Corp 57

8.5.1 Company Overview 57

8.6 bioMerieux SA 57

8.6.1 Company Overview 57

9 Appendix 58

9.1 Research Methodology 59

9.1.1 Coverage 59

9.1.2 Secondary Research 59

9.1.3 Primary Research 59

9.1.4 Market Modeling and Forecasting 60

9.1.5 Company Share Analysis 61

9.1.6 Benchmarking 62

9.2 GlobalData Consulting 63

9.3 Contact Us 63

9.4 Disclaimer 63

Table

Table 1: Cardiac Disease Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2018-2033 10

Table 2: Cardiac Disease Market, BRIC, Revenue ($m), USD Constant, 2018-2033 11

Table 3: Cardiac Disease Market, BRIC, Volume (Units), 2018-2033 12

Table 4: Cardiac Disease Market, BRIC, Volume (Units), 2018-2033 14

Table 5: Cardiac Disease Market, BRIC, Company Share by Revenue ($m), 2024 15

Table 6: Cardiac Disease Market, India, Revenue ($m), USD Constant, 2018-2033 16

Table 7: Cardiac Marker Tests Market, India, Revenue ($m), USD Constant, 2018-2033 18

Table 8: Cardiac Disease Market, India, Volume (Units), 2018-2033 20

Table 9: Cardiac Marker Tests Market, India, Volume (Units), 2018-2033 22

Table 10: Cardiac Disease Market, India, Average Price ($), 2018-2033 24

Table 11: Cardiac Disease Market, India, Company Share by Revenue ($m), 2024 25

Table 12: Cardiac Disease Market, Brazil, Revenue ($m), USD Constant, 2018-2033 26

Table 13: Cardiac Marker Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 28

Table 14: Cardiac Disease Market, Brazil, Volume (Units), 2018-2033 30

Table 15: Cardiac Marker Tests Market, Brazil, Volume (Units), 2018-2033 32

Table 16: Cardiac Disease Market, Brazil, Average Price ($), 2018-2033 34

Table 17: Cardiac Disease Market, Brazil, Company Share by Revenue ($m), 2024 35

Table 18: Cardiac Disease Market, China, Revenue ($m), USD Constant, 2018-2033 36

Table 19: Cardiac Marker Tests Market, China, Revenue ($m), USD Constant, 2018-2033 38

Table 20: Cardiac Disease Market, China, Volume (Units), 2018-2033 40

Table 21: Cardiac Marker Tests Market, China, Volume (Units), 2018-2033 42

Table 22: Cardiac Disease Market, China, Average Price ($), 2018-2033 44

Table 23: Cardiac Disease Market, China, Company Share by Revenue ($m), 2024 45

Table 24: Cardiac Disease Market, Russia, Revenue ($m), USD Constant, 2018-2033 46

Table 25: Cardiac Marker Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 48

Table 26: Cardiac Disease Market, Russia, Volume (Units), 2018-2033 50

Table 27: Cardiac Marker Tests Market, Russia, Volume (Units), 2018-2033 52

Table 28: Cardiac Disease Market, Russia, Average Price ($), 2018-2033 54

Table 29: Cardiac Disease Market, Russia, Company Share by Revenue ($m), 2024 55

Table 31: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 60

Figures

Figure 1: Cardiac Disease Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2018-2033 10

Figure 2: Cardiac Disease Market, BRIC, Revenue ($m), USD Constant, 2018-2033 11

Figure 3: Cardiac Disease Market, BRIC, Volume (Units), 2018-2033 12

Figure 4: Cardiac Disease Market, BRIC, Volume (Units), 2018-2033 13

Figure 5: Cardiac Disease Market, BRIC, Company Share (%), 2024 15

Figure 6: Cardiac Disease Market, India, Revenue ($m), USD Constant, 2018-2033 16

Figure 7: Cardiac Marker Tests Market, India, Revenue ($m), USD Constant, 2018-2033 17

Figure 8: Cardiac Disease Market, India, Volume (Units), 2018-2033 19

Figure 9: Cardiac Marker Tests Market, India, Volume (Units), 2018-2033 21

Figure 10: Cardiac Disease Market, India, Company Share (%), 2024 25

Figure 11: Cardiac Disease Market, Brazil, Revenue ($m), USD Constant, 2018-2033 26

Figure 12: Cardiac Marker Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 27

Figure 13: Cardiac Disease Market, Brazil, Volume (Units), 2018-2033 29

Figure 14: Cardiac Marker Tests Market, Brazil, Volume (Units), 2018-2033 31

Figure 15: Cardiac Disease Market, Brazil, Company Share (%), 2024 35

Figure 16: Cardiac Disease Market, China, Revenue ($m), USD Constant, 2018-2033 36

Figure 17: Cardiac Marker Tests Market, China, Revenue ($m), USD Constant, 2018-2033 37

Figure 18: Cardiac Disease Market, China, Volume (Units), 2018-2033 39

Figure 19: Cardiac Marker Tests Market, China, Volume (Units), 2018-2033 41

Figure 20: Cardiac Disease Market, China, Company Share (%), 2024 45

Figure 21: Cardiac Disease Market, Russia, Revenue ($m), USD Constant, 2018-2033 46

Figure 22: Cardiac Marker Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 47

Figure 23: Cardiac Disease Market, Russia, Volume (Units), 2018-2033 49

Figure 24: Cardiac Marker Tests Market, Russia, Volume (Units), 2018-2033 51

Figure 25: Cardiac Disease Market, Russia, Company Share (%), 2024 55

BRIC Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at BRIC Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests in real time.

  • Access a live BRIC Cardiac Disease Market Outlook to 2033: Cardiac Marker Tests dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more